Stephens Kristin

CIK 00018654901 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001865490

Recent Transactions

22 trades

Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-11-18$0.22/sh−36,133→ 0 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31$2.09/sh−6,104→ 36,133 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-10-31−17,000→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31+17,000→ 42,237 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-01$5.12/sh−4,218→ 25,237 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−2,000→ 4,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+2,000→ 17,789 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+11,666→ 29,455 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−11,666→ 23,334 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-11-01$2.22/sh−5,676→ 15,789 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-10-31+17,000→ 21,465 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-10-31−17,000→ 17,000 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-04-03$2.58/sh−623→ 4,465 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-03-31−2,000→ 6,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-03-31+2,000→ 5,088 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-02-16+35,000→ 35,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+44,500→ 44,500 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+34,000→ 34,000 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2022-04-01$1.12/sh−14,115→ 30,885 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-15+100,000→ 100,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+80,000→ 80,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+200,000→ 200,000 total

Companies

Syros Pharmaceuticals, Inc.
Chief Development Officer

Recent Filings

Address

C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE

CAMBRIDGE, MA, 02140

View on SEC.gov